ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2.Lancet1988; ii: 349
2.
StampferM.J., GoldhaberS.Z., YusufS., PetoR., HennekensC.H.Effects of intravenous streptokinase on acute myocardial infarction. Pooled results from randomized trialsN Engl J Med1982; 307: 1180
3.
Wilcox RG, Von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton, Jr., for the ASSET study group.Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).Lancet1988; ii: 525
4.
AIMS Trial Study Group.Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial.Lancet1988; i: 545
5.
Van de WerfF., ArnoldA.E.R.Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.Br Med J1988; 297: 1374
